Emerald Acquisition’s Altimmune ALT Stock Holding History

Emerald Acquisition’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$705K	Buy	+811	New	+$636K	﹤0.01%	2296

Other funds holding ALT

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Acquisition's ALT Position: Q3 2016 in Review

Emerald Acquisition opened a new position in Altimmune (ALT) in Q3 2016: 811 shares worth $705K. The stake represents ﹤0.01% of the portfolio and ranks #2296 among its holdings.

62 funds tracked by Wall St. Rank hold ALT as of Q3 2016.

Emerald Acquisition held 811 shares of Altimmune worth $705K as of Q3 2016.
Altimmune was a new Emerald Acquisition position in Q3 2016.
Altimmune made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2296 holding.
62 funds tracked by Wall St. Rank held Altimmune as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.